John T. McDevitt
Chief Scientist, Owner, Founder of OraLiva, INC., Inventor, Keynote Lecturer, Professor, Precision Diagnostics, Oncology
- Role
- Chief Scientist, Owner, Founder at Oraliva, Inc
- Location
- New York, NY, US
- LinkedIn followers
- 500 followers
About John T. McDevitt
Dr. John T. McDevitt has a strong track record of translating essential bioscience discoveries into real-world clinical practice. In this capacity, he serves as the Scientific Founder for several diagnostic companies. His most recent company, OraLiva, features clinical services and decision support tools capable of capturing diseases early before they spiral out of control.McDevitt also serves as a Professor for the Department Biomaterials at New York University College of Dentistry, is a member of NYU’s Bioengineering Institute and participates as a faculty member in the NYU Department of Chemical and Biomolecular Engineering within the Tandon School of Engineering. McDevitt and his team over the past decade have raised over $30M in Federal and Foundation support. His recent research has been sponsored by major programs funded by the NIH, the Bill and Melinda Gates Foundation, Cancer Prevention Research Institute of Texas, NASA and the United Kingdom’s Home Office Scientific Development Branch.McDevitt and his team have written more than 200 peer-reviewed scientific manuscripts and have contributed to more than 100 patents and patent applications. This work was recognized with “2016 AACC Wallace H. Coulter Lectureship Award,” “Best of What\'s New Award” in the Medical Device Category for 2008 by Popular Science as well as for the “Best Scientific Advances Award” in 1998 by the Science Coalition. Dr. McDevitt’s individual honors include the Presidential Young Investigator Award, the 2010 California Polytechnic Distinguished Alumni Award and the Exxon Education Award. Over the past 7 years, Dr. McDevitt has served as the Principal Investigator for 6 major clinical trials and 2 clinical pilot studies, all involving the programmable bio-nano-chip. Through these clinical efforts, mini-sensor ensembles are being developed for major diseases in the areas of oral cancer, cardiac heart disease, trauma, drugs of abuse, ovarian cancer and prostate cancer.
Experience
Chief Scientist, Owner, Founder
Apr 2020 — Present · US
OraLiva develops AI linked diagnostic devices that are suitable for early cancer detection.
Education
Stanford University
Ph.D., Physical Chemistry
1982 — 1987
California Polytechnic State University-San Luis Obispo
B.S., Chemistry
1979 — 1982
Skills
- Hardware Diagnostics
- Life Sciences
- Biosensors
- Uv/Vis
- Molecular Biology
- Fluorescence Microscopy
- Microscopy
- Mems
- Bioengineering
- Nanoparticles
- Science
- Biochemistry
- Genomics
- Proteomics
- Fluorescence
- Characterization
- Spectroscopy
- Biotechnology
- Research and Development (R&D)
- Chemistry
- Materials Science
- Biomedical Engineering
- Cancer
- Medical Devices
- Protein Chemistry
- Nanotechnology
- Lifesciences
- Sensors
- R&D
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.